Gut balance, a synbiotic supplement, increases fecal Lactobacillus paracasei but has little effect on immunity in healthy physically active individuals

Gut Microbes

Volumn 3, Issue 3, 2012, Pages 221-227

  West, Nicholas P ^a,b   Pyne, David B ^a,c   Cripps, Allan W ^d   Christophersen, Claus T ^e   Conlon, Michael A ^e   Fricker, Peter A ^a  

^a AUSTRALIAN INSTITUTE OF SPORT   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c Canberra Hospital   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

^e CSIRO   (Australia)

Author keywords

Acacia gum; Athletes; Gut balance; Immune function; Microbiota; Prebiotics; Synbiotics

Indexed keywords

BIOSOURCE GUT BALANCE; GAMMA INTERFERON; GUM ARABIC; IMMUNOGLOBULIN; INTERLEUKIN 12P70; INTERLEUKIN 16; INTERLEUKIN 18; LACTOFERRIN; PREBIOTIC AGENT; RAFTILINE; RAFTILOSE; SHORT CHAIN FATTY ACID; SYNBIOTIC AGENT; UNCLASSIFIED DRUG; CYTOKINE; FATTY ACID;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL COUNT; BACTERIUM IDENTIFICATION; BIFIDOBACTERIUM ANIMALIS; BLOATING; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; EXERCISE TEST; FECES LEVEL; FECES MICROFLORA; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; IMMUNITY; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; MALE; MUCOSAL IMMUNITY; NAUSEA; NONHUMAN; NORMAL HUMAN; PARALLEL DESIGN; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL; SELF REPORT; SUPPLEMENTATION; URINALYSIS; BACTERIAL LOAD; BLOOD; CHEMISTRY; CONTROLLED CLINICAL TRIAL; DIET; FECES; GASTROINTESTINAL TRACT; IMMUNOLOGY; ISOLATION AND PURIFICATION; LACTOBACILLUS; METHODOLOGY; MICROBIOLOGY; PHYSIOLOGY; SALIVA; SERUM;

ACACIA; BIFIDOBACTERIUM ANIMALIS; BOVINAE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS;

ADULT; BACTERIAL LOAD; CYTOKINES; DIET; DOUBLE-BLIND METHOD; FATTY ACIDS; FECES; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS; LACTOFERRIN; MALE; SALIVA; SERUM; SYNBIOTICS;

EID: 84930474278     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.19579     Document Type: Article

References (49)

1. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 2008; 88:1438-1446; PMID:18996881.
2. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 2011.
3. Christensen HR, Larsen CN, Kaestel P, Rosholm LB, Sternberg C, Michaelsen KF, et al. Immunomodulating potential of supplementation with probiotics: a doseresponse study in healthy young adults. FEMS Immunol Med Microbiol 2006; 47:380-390; PMID:16872374;http://dx.doi.org/10.1111/j.1574-695X.2006.00109.x.
4. Yamauchi K, Wakabayashi H, Hashimoto S, Teraguchi S, Hayasawa H, Tomita M. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv Exp Med Biol 1998; 443:261-265; PMID:9781368.
5. Cox AJ, Pyne DB, Saunders PU, Callister R, Gleeson M. Cytokine responses to treadmill running in healthy and illness-prone athletes. Med Sci Sports Exerc 2007; 39:1918-1926; PMID:17986898; http://dx.doi.org/10.1249/mss.0b013e318149f2aa.
6. Trøseid M, Seljeflot I, Arnesen H. The role of interleukin- 18 in the metabolic syndrome. Cardiovasc Diabetol 2010; 9:11; PMID:20331890; http://dx.doi.org/10.1186/1475-2840-9-11.
7. Braunstahl GJ, Fokkens WJ, Overbeek SE, KleinJan A, Hoogsteden HC, Prins JB. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Clin Exp Allergy 2003; 33:579-87; PMID:12752585;http://dx.doi.org/10.1046/j.1365-2222.2003.01652.x.
8. West NP, Pyne DB, Peake JM, Cripps AW. Probiotics, immunity and exercise: a review. Exerc Immunol Rev 2009; 15:107-126; PMID:19957873.
9. van Ommen B, Keijer J, Heil SG, Kaput J. Challenging homeostasis to define biomarkers for nutrition related health. Mol Nutr Food Res 2009; 53:795-804; PMID:19517455; http://dx.doi.org/10.1002/mnfr.200800390.
10. Chr Hansen A/S. Study summaries L. Casei 431. date accessed 28 November 2011 from http://www.chr-hansen.com/products/product-areas/probioticsfor-human-health/strains.html.
11. Zenhom M, Hyder A, de Vrese M, Heller KJ, Roeder T, Schrezenmeir J. Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARγ and peptidoglycan recognition protein 3. J Nutr 2011; 141:971-977; PMID:21451128;http://dx.doi.org/10.3945/jn.110.136176.
12. Borromei C, Careri M, Cavazza A, Corradini C, Elviri L, Mangia A, et al. Evaluation of Fructooligosaccharides and Inulins as Potentially Health Benefiting Food Ingredients by HPAEC-PED and MALDI-TOF MS. Int J Anal Chem 2009; 2009:530-639.
13. Nagpal R, Kaur A. Syn biotic effect of various prebiotics on in vitro activities of probiotic lactobacilli. Ecol Food Nutr 2011; 50:63-68; PMID:21888588;http://dx.doi.org/10.1080/03670244.2011.539161.
14. Calame W, Weseler AR, Viebke C, Flynn C, Siemensma AD. Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner. Br J Nutr 2008; 100:1269-1275; PMID:18466655;http://dx.doi.org/10.1017/S0007114508981447.
15. Powell T, Bailey J. Against placebos. Am J Bioeth 2009; 9:23-25; PMID:20013491; http://dx.doi.org/10.1080/15265160903244234.
16. Larsen CN, Nielsen S, Kaestel P, Brockmann E, Bennedsen M, Christensen HR, et al. Dose-response study of probiotic bacteria Bifidobacterium animalissubsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 2006; 60:1284-1293; PMID:16721394;http://dx.doi.org/10.1038/sj.ejcn.1602450.
17. Shioya M, Nakaoka K, Iizuka N, Sato M, Benno Y. Effect of fermented milk containing Bifidobacteriumlactis FK 120 on the fecal flora, with special reference to Bifidum species and fecal properties in elderly volunteers. Food Health and Nutrition Research (Journal of Nutritional Food) 2000; 33-44.
18. Kolida S, Meyer D, Gibson GR. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr 2007; 61:1189-1195; PMID:17268410; http://dx.doi.org/10.1038/sj.ejcn.1602636.
19. Meyer D, Stasse-Wolthuis M. The bifi dogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr 2009; 63:1277-1289; PMID:19690573; http://dx.doi.org/10.1038/ejcn.2009.64.
20. Gaón D, García H, Winter L, Rodríguez N, Quintás R, González SN, et al. Effect of Lactobacillus strainsand Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires) 2003; 63:293-298; PMID:14518142.
21. Gonzalez SN, Cardozo R, Apella MC, Oliver G. Bioth erapeutic role of fermented milk. Biotherapy 1994; 8:129-134; PMID:8924354; http://dx.doi.org/10.1007/BF01878496.
22. Nova E, Viadel B, Wärnberg J, Carreres JE, Marcos A. Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults. J Med Food 2011; 14:79-85; PMID:21244240; http://dx.doi.org/10.1089/jmf.2008.0328.
23. Castellazzi AM, Valsecchi C, Montagna L, Malfa P, Ciprandi G, Avanzini MA, et al. In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei I 1688, Lactobacillus salivarius I 1794, and their mixture (PSMIX). Immunol Invest 2007; 36:413-21; PMID:17691023; http://dx.doi.org/10.1080/08820130701361160.
24. Glass WG, Sarisky RT, Vecchio AM. Not-so-sweet sixteen: the role of IL-16 in infectious and immunemediated inflammatory diseases. J Interferon Cytokine Res 2006; 26:511-520; PMID:16881862; http://dx.doi.org/10.1089/jir.2006.26.511.
25. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011; 11:607-15; PMID:21818123; http://dx.doi.org/10.1038/nri3041.
26. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121:580-91; PMID:11522742;http://dx.doi.org/10.1053/gast.2001.27224.
27. Alberda C, Gramlich L, Meddings J, Field C, McCargar L, Kutsogiannis D, et al. Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2007; 85:816-823; PMID:17344505.
28. Pals KL, Chang RT, Ryan AJ, Gisolfi CV. Effect of running intensity on intestinal permeability. J Appl Physiol 1997; 82:571-576; PMID:9049739.
29. West NP, Pyne DB, Kyd JM, Renshaw GM, Fricker PA, Cripps AW. The effect of exercise on innate mucosal immunity. Br J Sports Med 2010; 44:227-231; PMID:18499767; http://dx.doi.org/10.1136/bjsm.2008.046532.5.2001.
30. Gleeson M, Bishop NC, Oliveira M, Tauler P. Daily pro biotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab 2011; 21:55-64; PMID:21411836.
31. Cox AJ, Pyne DB, Saunders PU, Fricker PA. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 2010; 44:222-226; PMID:18272539;http://dx.doi.org/10.1136/bjsm.2007.044628.
32. West NP, Pyne DB, Cripps AW, Hopkins WG, Eskesen DC, Jairath A, et al. Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratorytract illness symptoms: a randomised control trial in athletes. Nutr J 2011; 10:30; PMID:21477383; http://dx.doi.org/10.1186/1475-2891-10-30.
33. Rizzardini G, Eskesen D, Calder PC, Capetti A, Jespersen L, Clerici M. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp lactis, BB-12(R) and Lactobacillus paracasei ssp paracasei, L. casei 431(R) in an influenza vaccination model: a randomised, double-blind, placebo-controlledstudy. Br J Nutr 2012; 107:876-84; PMID:21899798;http://dx.doi.org/10.1017/S000711451100420X.
34. Lee H, Martin DT, Anson JM, Grundy D, Hahn AG. Physiological characteristics of successful mountain bikers and professional road cyclists. J Sports Sci 2002; 20:1001-1008; PMID:12477010; http://dx.doi.org/10.1080/026404102321011760.
35. Camilleri M, Nadeau A, Lamsam J, Nord SL, Ryks M, Burton D, et al. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil 2010; 22:15-26; PMID:19614866.
36. Fricker PA, Pyne DB, Saunders PU, Cox AJ, Gleeson M, Telford RD. Influence of training loads on patterns of illness in elite distance runners. Clin J Sport Med 2005; 15:246-252; PMID:16003039; http://dx.doi.org/10.1097/01.jsm.0000168075.66874.3e.
37. Abell GC, Cooke CM, Bennett CN, Conlon MA, McOrist AL. Phylo types related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. FEMS Microbiol Ecol 2008; 66:505-15; PMID:18616586;http://dx.doi.org/10.1111/j.1574-6941.2008.00527.x.
38. Clarke K, Warwick R. A further biodiversity index applicable to species lists: variation in taxonomic distinctness. Mar Ecol Prog Ser 2001; 216:265-278; ttp://dx.doi.org/10.3354/meps216265.
39. Abell GCJ, Christophersen CT, McOrist AL, Clarke JM. Dietary resistant and butyrylated starches have different effects on the faecal bacterial flora of azoxymethane- treated rats. Br J Nutr 2011; 105:1480-1485; PMID:21255474; http://dx.doi.org/10.1017/S0007114510005349.
40. Bajka BH, Topping DL, Cobiac L, Clarke JM. Butyrylated starch is less susceptible to enzymic hydrolysis and increases large-bowel butyrate more than high-amylose maize starch in the rat. Br J Nutr 2006; 96:276-282; PMID:16923221; http://dx.doi.org/10.1079/BJN20061807.
41. Stang A, Poole C, Kuss O. The ongoing tyranny of statistical significance testing in biomedical research. Eur J Epidemiol 2010; 25:225-230; PMID:20339903;http://dx.doi.org/10.1007/s10654-010-9440-x.
42. Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc 2009; 41:3-13; PMID:19092709; http://dx.doi.org/10.1249/MSS.0b013e31818cb278.
43. Cohen J. Statistical power analysis for the behavioral sciences, Hillsdale NJ. Lawrence Erlbaum 1988.
44. Hopkins WG. Estimating sample size for magnitudebased inferences. Sports Science 2006; 10:63-70.
45. Denman SE, McSweeney CS. Development of a real-time PCR assay for monitoring anaerobic fungal and cellulolytic bacterial populations within the rumen. FEMS Microbiol Ecol 2006; 58:572-582;PMID:17117998; http://dx.doi.org/10.1111/j.1574-6941.2006.00190.x.
46. Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP. Detection of Lactobacillus, Pediococcus, Leuconostoc and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 2001; 67:2578-2585; PMID:11375166; http://dx.doi.org/10.1128/AEM.67.6.2578-85.2001.
47. Heilig HG, Zoetendal EG, Vaughan EE, Marteau P, Akkermans AD, de Vos WM. Molecular diversity of Lactobacillus spp and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 2002; 68:114-123; PMID:11772617; http://dx.doi.org/10.1128/AEM.68.1.114-23.2002.
48. Byun R, Nadkarni MA, Chhour KL, Martin FE, Jacques NA, Hunter N. Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol 2004; 42:3128-3136; PMID:15243071;http://dx.doi.org/10.1128/JCM.42.7.3128-36.2004.
49. Ventura M, Reniero R, Zink R. Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Appl Environ Microbiol 2001; 67:2760-2765; PMID:11375192; http://dx.doi.org/10.1128/AEM.67.6.2760-5.2001.